Biovail Corp. (BVF, BVF.TO) announced that FDA has accepted its abbreviated new drug application or ANDA for a generic formulation of 200mg, 300mg and 400mg strengths of quetiapine fumarate extended-release tablets or Quetiapine XR.
AstraZeneca Pharmaceuticals LP (AZN) has been marketing the drug under the name Seroquel XR and has generated U.S. revenue of approx. $166 million in the twelve-month period ended September 30, 2008. Seroquel XR is an antipsychotic agent indicated for the treatment of schizophrenia and bipolar disorder.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.